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eratins 8 and 18 belong to the keratin family of inter-
mediate ﬁlament (IF) proteins and constitute a hall-
mark for all simple epithelia, including the liver.
Hepatocyte IFs are made solely of keratins 8 and 18 (K8/
K18). In these cells, the loss of one partner via a targeted
 
null mutation in the germline results in hepatocytes lacking
K8/K18 IFs, thus providing a model of choice for examin-
ing the function(s) of simple epithelium keratins. Here, we
report that K8-null mouse hepatocytes in primary culture
and in vivo are three- to fourfold more sensitive than wild-
type (WT) mouse hepatocytes to Fas-mediated apoptosis
after stimulation with Jo2, an agonistic antibody of Fas
ligand. This increased sensitivity is associated with a higher
and more rapid caspase-3 activation and DNA fragmenta-
K
 
tion. In contrast, no difference in apoptosis is observed be-
tween cultured K8-null and WT hepatocytes after addition
of the Fas-related death-factors tumor necrosis factor (TNF)
 
 
 
 or TNF-related apoptosis-inducing ligand. Analyses of
the Fas distribution in K8-null and WT hepatocytes in cul-
ture and in situ demonstrate a more prominent targeting of
the receptor to the surface membrane of K8-null hepato-
cytes. Moreover, altering Fas trafﬁcking by disrupting micro-
tubules with colchicine reduces by twofold the protection
generated against Jo2-induced lethal action in K8-null ver-
sus WT hepatocytes. Together, the results strongly suggest
that simple epithelium K8/K18 provide resistance to Fas-
mediated apoptosis and that this protection occurs through
a modulation of Fas targeting to the cell surface.
 
Introduction
 
Keratins constitute the most diverse family of intermediate
filament (IF)* proteins, with over
 
 
 
20 proteins subdivided
into type I (K9–K20) and type II (K1–K8) sub-classes
(McLean and Lane, 1995; Fuchs and Cleveland, 1998;
Chou and Goldman, 2000). Keratin genes are coordinately
expressed in pairs in epithelia, i.e., specific type I/type II het-
erodimers, with more than half of them in squamous epithe-
lia such as epidermis. Simple epithelial cells, like those of the
liver, all contain the keratins 8 and 18 (K8/K18) pair usually
in combination with two to three other keratins; but in
hepatocytes, the IFs consist solely of the K8/K18 pair. Since
the loss of one keratin partner normally leads to the degrada-
tion of the other (Omary and Ku, 1997; Oshima et al.,
1996; Ku et al., 1999), hepatocytes provide a unique cell
 
model to address the function(s) of simple epithelium ker-
atins (Loranger et al., 1997; Omary and Ku, 1997). For in-
stance, by using a K8-null mouse model generated via a
targeted mutation in the germline (Baribault et al., 1994),
we have shown that K8/K18 IFs contribute to the mainte-
nance of the integrity of the hepatocyte surface membrane
in response to mechanical stress (Loranger et al., 1997).
However, a uniquely mechanical function for K8/K18 IFs
does not fit with results showing that K8-null, K18-null and
Arg89
 
→
 
Cys K18 mutant mice are highly sensitive to chem-
ical stresses such as those provided by griseofulvin and acet-
aminophen (Cadrin et al., 1996; Omary and Ku, 1997;
Zatloukal et al., 2000); fibroblastic L cells transfected with
 
K8 and K18 exhibit an increased resistance to chemother-
apeutic agents (Bauman et al., 1994), and normal and
malignant epithelial cells exhibiting various K8 or K18
perturbations are more sensitive to tumor necrosis factor
 
(TNF)-
 
 
 
–induced death in the presence of cycloheximide
(CHX) (Caulin et al., 2000). Thus, K8/K18 exhibit protec-
tive features in response to mechanical stress, but also to
other forms of stress that can lead to cell death.
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Apoptosis, a form of programmed cell death that gener-
ates a minimal inflammatory response, is required to main-
tain normal tissue homeostasis or to eliminate abnormal
cells or cells damaged by various insults (Thompson, 1995;
Peter and Krammer, 1998). Extensive in vitro studies on the
role of three death-inducing members of the TNF family,
TNF-
 
 
 
, Fas ligand (FasL), and TNF-related apoptosis-
inducing ligand (TRAIL), using a wide range of conven-
tional cell lines as model systems have helped to elucidate
the complex but interacting signaling pathways that underlie
apoptosis (Ashkenazi and Dixit, 1998; Krammer, 1999). In
particular, stimulation of Fas by FasL induces receptor trimer-
ization at the surface membrane, which allows the recruit-
ment of the adapter protein FADD which, with the initiator
procaspase-8, forms the death-inducing signaling complex
(Kischkel et al., 1995; Chinnaiyan et al., 1996). This trig-
gers procaspase-8 proteolytic activation, which in turn ini-
tiates in type I cells a controlled proteolysis of proteins in-
cluding effector procaspases like procaspase-3 and various
downstream substrates (Caulin et al., 1997; Zheng et al.,
1998; Hengartner, 2000). Fas stimulation can trigger a sec-
ond caspase pathway that is mediated in type II cells by the
release of cytochrome c from mitochondria and the subse-
quent activation of the initiator procaspase-9 (Hengartner,
2000; Kaufmann and Gores, 2000; Krammer, 2000).
 
 
 
In
contrast to FasL, TNF-
 
 
 
 activates two receptors, TNF-
R1 and TNF-R2 (Baker and Reddy, 1998; Ashkenazi
and Dixit, 1999), which promote cell proliferation after
TRADD-mediated binding to an appropriate member of
the TRAF family. However, in cells sensitized with CHX or
actinomycin D (Act D), oligomerized TNF-R1, but not
TNF-R2 which lacks the death domain, can lead to apopto-
sis after binding to TRADD, which recruits FADD to acti-
vate the caspase pathway (Chinnaiyan et al., 1996; Hsu et
al., 1996). Stimulation of TRAIL receptors, i.e., TRAIL-R1
and TRAIL-R2, can in the presence of CHX lead to apopto-
sis via a sequence of events that correspond to those trig-
gered by Fas (Kischkel et al., 2000; Sprick et al., 2000). In
various cell lines, CHX and Act D sensitize for Fas-induced
apoptosis by downregulating the synthesis of c-FLIP, a labile
protective protein homologous to caspase-8 but exhibiting
an inactive catalytic site, so that the balance between cell sur-
vival and death can be modulated by the relative concentra-
tion of the death receptor and c-FLIP (Tschopp et al., 1998;
Scaffidi et al., 1999; Fulda et al., 2000). However, cell sur-
vival can also be obtained through the action of external sig-
nals, like those generated by epidermal growth factor (EGF).
In that case, protection against cell death results from the ac-
tivation of the Akt pathway (Kulik et al., 1997; Gibson et
al., 1999). The relative contribution of these pathways is
particularly dependent on the cell type and the cellular con-
text (Kaufmann and Gores, 2000; Tepper et al., 2000).
Hepatocytes are among the cell types that contain the
highest level of Fas (Nagata, 1999). Accordingly, a single in-
jection of the agonistic antibody of FasL Jo2 into mice is suf-
ficient to induce massive hepatocyte apoptosis and rapid
death of the animal (Ni et al., 1994; Lacronique et al.,
1996). This high sensitivity to Fas-mediated apoptosis results
from the fact that the Fas/FasL system provides an efficient
means to exclude from the liver the hepatocytes that have
been damaged by various insults (Lacronique et al., 1996;
Nagata, 1999; Sodeman et al., 2000). Upon stimulation, Fas
is targeted to the surface membrane through the Golgi-sort-
ing compartment, and this transfer depends on functional
microtubules (Feng and Kaplowitz, 2000). The current view
is that this microtubule-dependent targeting of Fas provides
an efficient mechanism to modulate the Fas density at the
surface membrane and to avoid any spontaneous apoptosis
that could result from an excess of cell surface Fas.
In the work reported here, we investigate the role of K8/
K18 in regulating Fas-mediated apoptosis in mouse hepato-
cytes in primary culture and in vivo. The results show that
Jo2 stimulation of Fas generates a higher apoptotic response
in K8-null than in wild-type (WT) mouse hepatocytes that
is directly associated with a higher and more rapid activation
of its signaling pathway. In addition, analyses of Fas traffick-
ing in hepatocytes, treated or non-treated with the micro-
tubule-disrupting agent colchicine, demonstrate that the
higher K8-null sensitivity to Jo2 is associated with increased
Fas targeting to the surface membrane. This points to a ma-
jor role of simple epithelium keratins in regulating Fas traf-
ficking and thus apoptosis sensitivity.
 
Results
 
Increased sensitivity of K8-null hepatocytes to 
Fas-mediated apoptosis
 
We determined the sensitivity of K8-null and WT mouse
hepatocytes to Jo2, using the two complementary experi-
mental approaches provided by primary culture and whole
liver in vivo. After 18 h in culture, hepatocytes formed a
dense cell monolayer exhibiting canaliculi equivalent to
those formed by hepatocytes in vivo (not shown). The hepa-
tocyte’s sensitivity to Jo2 was assessed quantitatively by
counting apoptotic nuclei. At day 2 after seeding, K8-null
hepatocytes were three- to fourfold more sensitive than WT
hepatocytes to the addition of Jo2 in the range of 0.05–0.5
 
 
 
g/ml (Fig. 1 A), and the response reached a maximum at
8 h after treatment (Fig. 1 B). At that time, essentially all the
apoptotic hepatocytes remained attached to the culture
substratum. Beyond that timepoint, a low percentage of the
apoptotic cells gradually detached, but even at 24 h after
treatment, the difference in cell death between K8-null and
WT hepatocytes remained comparable whether or not the
detached apoptotic cells were included in the counting (not
shown). At a high Jo2 concentration, the loss of K8/K18
had a reduced effect on Fas-mediated apoptosis, suggesting
that the protective resistance provided by K8/K18 is less effi-
cient upon a massive Fas stimulation (Fig. 1 A). The same
three- to fourfold differential response of K8-null versus WT
hepatocytes to Fas-mediated apoptosis was found at 3 h after
seeding when most of the cells were still dispersed on the
culture substratum, indicating that the increased sensitivity
of K8-null hepatocytes was not dependent on cell–cell adhe-
sion (not shown). A relevant control was to determine
whether the observed phenotype in these K8-null hepato-
cytes was rescued after the reinsertion of the WT K8 pro-
tein. As shown in Fig. 1 C, the transfer of a complete K8
cDNA in 48-h K8-null hepatocyte cultures with a retroviral
vector yielded a resistance to Fas-mediated apoptosis at 5 d 
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after seeding equivalent to that observed with WT hepato-
cytes (Fig. 1 A). Assessment of apoptosis of nontransduced
WT hepatocytes at 5 d after seeding (not shown) yielded a
response essentially identical to that obtained at 3 d (Fig. 1
A). The transfer of a nonrelated cDNA (thymidine kinase
[TK]) confirmed that the rescue obtained above was due
solely to K8 reexpression (Fig. 1 C).
We then compared the response of K8-null and WT
hepatocytes to Jo2 in vivo. We first determined the response
to Jo2 at the whole mouse level to select a dose at which the
hepatocyte viability could be readily monitored by measur-
ing the amount of alanine aminotransferase (ALT) released
in serum. Although a single administration of Jo2 at 200
 
 
 
g/kg resulted in a massive killing of K8-null and WT mice,
most of them remained alive at 75 
 
 
 
g/kg (Fig. 1 D). In fact,
the dose–response curve showed a LD50 of 150 
 
 
 
g/kg. As
shown in Fig. 1 E, comparative evaluation of the serum ALT
activity levels at 8 h after injection of 75 
 
 
 
g/kg Jo2 yielded a
hepatocyte death response threefold higher in K8-null than
in WT hepatocytes. Scanning of serial tissue sections con-
firmed that the number of apoptotic nuclei, as determined
by acridine orange staining, was higher in K8-null liver (not
shown). These in vivo findings corroborate well the in-
creased sensitivity to Jo2 obtained in primary K8-null hepa-
tocyte cultures.
 
K8/K18 interfere selectively with Fas-mediated 
cell death
 
Apoptosis can be induced by other members of the TNF re-
ceptor family, such as those activated by TNF-
 
 
 
 and TRAIL,
respectively. We thus evaluated whether the protective role
played by K8/K18 against Fas-mediated hepatocyte death
was also applicable to those death receptors. As shown in Fig.
2 A, the addition of TNF-
 
 
 
 to primary cultured hepatocytes
induced a low level of apoptosis, but no significant difference
was observed between WT and K8-null hepatocytes. Simi-
larly, the addition of TRAIL yielded a low apoptotic response
of WT hepatocytes on which the loss of K8/K18 had no in-
fluence (Fig. 2 A). This lack of response for hepatocytes in
primary culture is consistent with previous findings obtained
in various established cell lines (Jo et al., 2000).
In various cell models, the apoptotic process can be trig-
gered by TNF-
 
 
 
 in the presence of inhibitors of protein
(CHX) or RNA (Act D) synthesis (Senaldi et al., 1998;
West et al., 1999; Caulin et al., 2000). These agents were
used here as tools to modulate the hepatocyte response to
the death ligands. Although we found that CHX or Act D
sensitization led to an increase in TNF-
 
 
 
–mediated apopto-
sis of both WT and K8-null hepatocytes, the loss of K8 did
not lead to any differential cell death activation whether
TNF-
 
 
 
 was added at 10 ng/ml (Fig. 2 A) or at 100 ng/ml
(not shown). Similar results were obtained after the addition
of TRAIL at 1.0 
 
 
 
g/ml (Fig. 2 A) or 0.1 
 
 
 
g/ml (not shown)
to WT and K8-null hepatocytes submitted to the same sen-
sitization protocol. In contrast, under the same conditions,
the addition of Jo2 resulted in 100% death for both K8-null
and WT hepatocytes (Fig. 2 A). As observed before with T
cells (Tang et al., 1999), CHX added alone at 5 
 
 
 
g/ml in-
duced a low level of apoptosis in both WT and K8-null
hepatocytes, but had no differential effect (Fig. 2 A); at
50 
 
 
 
g/ml, the level of apoptosis increased to 10.6% for
WT hepatocytes and 15.9% for K8-null hepatocytes (not
shown). Together, the data indicate a preferential link be-
tween K8/K18- and Fas-mediated events.
We next looked at the activation of caspase-3, a represen-
tative member of the Fas-signaling pathway, during the 24-h
Figure 1. The loss of K8/K18 leads to a 
prominent increase in hepatocyte sensi-
tivity to Fas-mediated apoptosis both in 
culture and in vivo. (A) After 24 h in the 
presence of 0.5  g/ml Jo2, K8-null hepa-
tocytes in primary culture are three to 
four times more responsive to Jo2-
induced death than WT, as measured by 
Acridine orange staining of DNA frag-
mentation (inset). The differential re-
sponse reaches saturation at a Jo2 dose 
 2.5  g/ml. C, control. (B) Time–
response curves obtained at a dose of 
0.5  g/ml demonstrate that the differen-
tial response between K8-null and WT 
hepatocytes reaches a maximum at 8 h 
of induction. (C) The transfer of a com-
plete K8 cDNA into 48-h K8-null hepa-
tocyte cultures using a retroviral vector 
yields a resistance to apoptosis in 
response to 0.5  g/ml Jo2 equivalent to 
that observed with WT hepatocytes. The 
expression of a TK cDNA does not 
change the K8-null hepatocyte response 
to Jo2, confirming that the rescue ob-
served above is due to K8 reexpression. 
Note that the apoptotic response was 
assessed on GFP-expressing hepatocytes only. (D) The assessment of the Fas dose–response curve in vivo yields a LD50 (dashed line) of  150 
 g/kg. At a dose of 75  g/kg, most of the WT mice remain alive at 24 h after injection. (E) Measurements of ALT activity levels at 8 h after Jo2 
injection (75  g/kg) showing that K8-null hepatocytes are three times more affected than WT hepatocytes. n   11 mice; *p-value   0.02. 
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period after Jo2 stimulation of cultured hepatocytes. The in-
creased sensitivity of K8-null hepatocytes to Fas-mediated
apoptosis over that of WT hepatocytes was associated with a
more prominent processing of caspase-3, as revealed by an
increased generation of the p17 fragment (Fig. 2 B). The ac-
tivation started at 2 h and reached a maximum already at 4 h
in K8-null hepatocytes, whereas it started at 4 h and gradu-
ally increased during the following 24-h period in WT hepa-
tocytes. Furthermore, assessment of the hepatocyte’s sensi-
tivity to Jo2 by DNA laddering showed a higher and more
rapid DNA fragmentation in K8-null than in WT hepato-
cytes (Fig. 2 C). This corroborates with the data obtained by
direct counting of fragmented nuclei.
Another pathway that can lead to apoptosis in hepatocytes
is that activated by TGF-
 
 
 
 (Roberts et al., 2000). We thus
assessed whether the loss of K8/K18 altered the response of
hepatocytes to this multifunctional factor. Although its ad-
dition yielded a low level of apoptosis, it did not lead to a
differential response between K8-null and WT hepatocytes,
which further supports the high specificity of the interplay
between K8/K18 and Fas-mediated apoptosis (not shown).
Cells can be protected from Fas-mediated apoptosis via
the activation of survival pathways by growth factors like
EGF (Gibson et al., 1999). Considering the major role of
 
EGF in hepatocyte growth regulation, we asked whether it is
also involved in the protective resistance provided by K8/
K18 in these cells. Notably, the growth-promoting activity
occurs via the activation of the ERK-signaling pathway,
whereas the protective effect takes place through the activa-
tion of the Akt-signaling pathway (Gibson et al., 1999; Rob-
erts et al., 2000).
 
 
 
With regard to growth-promoting activity
of EGF, we found that, although the ERK pathway was al-
ready primed in K8-null hepatocytes and little in WT hepa-
tocytes, the addition of EGF led to essentially equivalent in-
creases in ERK activation in both cell populations (Fig. 3 A).
Comparable increases in Akt phosphorylation levels were
observed in K8-null and WT hepatocytes after the addition
of either 20 or 200 ng/dish EGF (Fig. 3 A), indicating that
the loss of K8/K18 does not affect this EGF protection
against Fas-mediated apoptosis. In line with these data on
EGF-induced Akt activation, increasing the EGF concentra-
tion to 200 ng/dish was sufficient to decrease the Fas-
induced apoptosis of K8-null hepatocytes to a level compa-
rable to that of WT hepatocytes (Fig. 3 B).
 
K8/K18 IFs modulate Fas targeting to the cell surface
 
Previous work performed on mouse hepatocytes in situ and
in monolayer culture have shown that cell sensitivity to Fas-
mediated apoptosis is linked to the receptor density at the
surface (Sodeman et al., 2000). Here, our immunofluores-
cence staining analyses in culture indicated that in contrast
to the regional localization found at the surface membrane
of WT hepatocytes, Fas was largely distributed along large
portion of the membrane in K8-null hepatocytes. Notably,
in WT hepatocytes, where K8/K18 were shown to be
mainly localized at the surface membrane (Fig. 4 A), Fas
was largely localized in the Golgi area (Fig. 4 A, merged im-
ages), whereas in K8-null hepatocytes Fas was preferentially
Figure 2. A preferential link exists between K8/K18 protection and 
Fas signaling. (A) The addition of TNF-  (10 ng/ml), TRAIL (1.0  g/
ml), or Jo2 (0.5  g/ml) alone or in combination with CHX (5  g/ml) 
or Act D (0.5  g/ml) to primary cultured WT or K8-null hepatocytes 
only show differential response to Jo2. (B) Western blot analysis of 
caspase-3 activation after Jo2 induction shows that procaspase-3 
(p32) is cleaved to an active form (p17) more rapidly in K8-null than 
in WT hepatocytes. The tubulin blot used here as control shows no 
significant variation in the cellular content of this cytoskeletal pro-
tein. (C) The DNA ladder appears higher and more rapid in K8-null 
hepatocytes than in WT hepatocytes after Jo2 stimulation.
Figure 3. The EGF-signaling pathway is not involved in the pro-
tection by K8/K18 against Fas-mediated apoptosis. (A) At a dose of 
20 or 200 ng/dish, EGF activation of ERK and Akt, as determined by 
the phosphorylation level of Thr 202/Tyr 204 (ERK) and Ser 473 
(Akt), occurs essentially to identical levels in both WT and K8-null 
hepatocytes. (B) Increasing the EGF concentration to 200 ng/dish 
decreased the Fas-induced apoptosis of K8-null hepatocytes to a 
level comparable to that of WT hepatocytes. 
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detected at the surface. In light of this shift in Fas targeting
to the surface membrane, we next analyzed the Fas content.
As demonstrated in Fig. 4 B, the total content of the death
receptor was not affected by the K8-null mutation, thus
suggesting that K8/K18 modulate Fas targeting to the sur-
face membrane.
In light of these new findings obtained with hepatocytes
in monolayer culture, we next used immunofluorescence
microscopy to verify the Fas distribution at the surface of
hepatocytes in situ. As in culture, a higher Fas density was
observed in K8-null hepatocytes (Fig. 5 A); this change was
not associated with a variation in Fas content (Fig. 5 B).
Moreover, our FACS
 
®
 
 analysis of freshly isolated hepato-
cytes (Fig. 5 C) allowed a quantification of the fluorescence
mean on live cells, and overall, the data demonstrated a sig-
nificant (30%) increase in Fas density at the surface of K8-
null hepatocytes (Fig. 5 D).
The proper trafficking of Fas between the Golgi-sorting
compartment and the surface membrane involves microtu-
bules (Feng and Kaplowitz, 2000; Sodeman et al., 2000).
Accordingly, treatment of mouse hepatocytes with colchi-
cine in vivo impairs Fas transfer to the surface and results in
a protection against Fas-mediated apoptosis (Feng and Kap-
lowitz, 2000). Here, we observed that the addition of col-
chicine protects WT but not K8-null hepatocytes against
Fas-mediated apoptosis in primary cultures, both in the ab-
sence or presence of Act D sensitization (Fig. 6 A). The col-
chicine treatment resulted in a massive microtubule depoly-
merization (Fig. 6 B). Under these conditions, a reduced Fas
density was observed at the surface membrane in association
with a major localization in the Golgi area in WT hepato-
cytes (Fig. 6 C). In contrast, K8-null hepatocytes exhibited a
large proportion of Fas at the surface membrane, with a low
signal in the Golgi area (Fig. 6 C). Finally, since this micro-
tubule-dependent modulation of Fas targeting has been
shown recently to reduce the mouse mortality induced by
Jo2 (Feng and Kaplowitz, 2000), we assessed K8-null versus
WT mouse survival as a function of time after an injection
of 400 
 
 
 
g/kg colchicine 24 h before an i.p. injection of 200
 
 
 
g/kg Jo2. As shown in Fig. 6 D, the colchicine pretreat-
ment resulted in a twofold lower survival of K8-null mice
compared with that of WT mice, confirming the findings
observed with hepatocytes in primary culture. On these
grounds, both the in vitro and in vivo data suggest an inter-
play between K8/K18, microtubule integrity, and Fas target-
ing to surface membrane.
Figure 4. Fas targeting is affected by the loss of K8/K18 in cultured hepatocytes. (A) Immunostaining of WT hepatocytes showing that K8 
(green in the merged picture) is localized at the surface membrane, whereas Fas (red in the merge) is mostly localized in the Golgi area (blue 
in the merge). The identity of the Golgi compartment was confirmed by detecting a standard marker, mannosidase II (blue in the merge). In 
contrast, Fas is largely present at the surface membrane in K8-null hepatocytes, with little in the Golgi area. (B) Western blot showing that the 
Fas content does not vary between WT and K8-null hepatocytes. Bars, 10  m. 
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Discussion
 
We have reported previously that simple epithelium K8/
K18 IFs are required for the maintenance of the mechanical
integrity of the hepatocyte surface membrane (Loranger et
al., 1997). Much of the knowledge accumulated so far on
the nonmechanical role of K8/K18 has come from biochem-
ical observations, e.g., keratin phosphorylation status, made
in nonhepatic simple epithelium-derived cell lines in culture
and also in hepatocytes in vivo in response to various insults,
including chemical stresses (Ku et al., 1996). Here, we pro-
vide the first direct evidence for a functional link between
Fas and K8/K18 in hepatocytes, in a manner that excludes
the participation of the TNF-
 
 
 
 and TRAIL receptors. This
protective resistance provided by K8/K18 is mechanistically
linked to a microtubule-dependent modulation of Fas tar-
geting to the surface membrane. The relevant components
of the Fas-signaling pathways in relation to the relevant cy-
toskeletal networks, the Golgi compartment, and the surface
membrane are depicted in Fig. 7.
 
K8/K18 and Fas functionally interact in 
a selective manner
 
The experimental strategy we used to define the functional
link between K8/K18- and Fas-mediated events was based on
the interplay between Fas, TNF-
 
 
 
, and TRAIL at the early
steps of the Fas-signaling pathway. The first hint of the selec-
tivity of this interaction came from the data observed be-
tween K8-null and WT hepatocytes in culture, which show
that the K8/K18 loss has no differential effect on the re-
sponse to TNF-
 
 
 
 or TRAIL alone or in combination with
CHX or Act D, respectively. These inhibitors of protein and
RNA synthesis have been shown to modulate the response of
various cell types, including hepatocytes, to death ligands
(Leist et al., 1994; Ni et al., 1994; Senaldi et al., 1998; West
et al., 1999; Caulin et al., 2000; Streetz et al., 2000). Our
findings confirm previous data showing that the addition of
CHX highly sensitizes cultured hepatocytes to apoptosis me-
diated by Fas, TNF-
 
 
 
, and TRAIL (Ni et al., 1994; West et
al., 1999; Streetz et al., 2000). The present findings further
indicate that under experimental conditions in which either
CHX or ActD alone result in a low level of hepatocyte apop-
tosis, ActD constitutes a better sensitizer than CHX for
TNF-
 
 
 
–mediated apoptosis (Fig. 2). In various cell lines,
these metabolic inhibitors sensitize for Fas-induced apoptosis
by downregulating the synthesis of c-FLIP (Fig. 7), so that
the balance between cell survival and death can be modulated
by the relative concentration of death receptor and c-FLIP
(Tschopp et al., 1998; Scaffidi et al., 1999; Fulda et al.,
2000). Hence, an explanation for our data showing a prefer-
ential increase in apoptosis of K8-null over WT hepatocytes
at a high CHX concentration (50 
 
 
 
g/ml) might be that a
drastic c-FLIP reduction in K8-null hepatocytes, exhibiting a
higher Fas density at the surface, favors Fas clustering and
initiates a higher level of apoptosis even in the absence of the
ligand. Our present findings with primary cultured hepato-
cytes contrast with data reported recently by Caulin et al.
(2000) using cell lines derived from mouse endoderm and
mammary glands, where perturbations in the expression or
organization of K8/K18 led to a higher sensitivity to TNF-
 
 
 
–induced cell death in the presence of CHX. This discrep-
ancy might result from the relative contribution of Fas- ver-
sus TNF-R1/R2–induced apoptosis in cells of different lin-
eage and differentiation status (Kaufmann and Gores, 2000).
Nevertheless, our comparative assessment here of the capacity
of stimulated Fas, TNF-R1/R2, or TRAIL receptors to medi-
ate K8-null versus WT hepatocyte apoptosis clearly points at
Fas as the prime target for K8/K18-induced resistance of
apoptosis in this differentiated simple epithelial cell type.
 
K8/K18 do not interfere with the EGF-induced survival
 
Previous data have established that a EGF-induced protec-
tion normally occurs in type II cells, in which Fas-mediated
cell death is dependent on mitochondria (Krammer, 2000).
Hepatocytes resemble type II cells, and as shown in Fig. 7,
the EGF-induced survival results from the activation of the
Akt-signaling pathway, which in turn blocks the mitochon-
Figure 5. Fas targeting is affected by the loss of K8/K18 in the liver 
in vivo. (A) Immunostaining showing that K8 is localized at the 
surface membrane in WT hepatocytes, whereas Fas is mostly 
detected in the cytoplasm. In contrast, Fas is largely localized at the 
surface membrane in K8-null hepatocytes. (B) Western blot demon-
strating that no difference in Fas content exists between livers from 
three WT mice and three K8-null mice, before or even after Jo2 injec-
tion (75  g/kg). (C) FACS
® analysis showing a shift in Fas density on 
the surface of freshly isolated living K8-null hepatocytes over that of 
WT hepatocytes. (D) Fluorescence means derived from data in C, 
showing a significant (30%) increase in Fas density at the surface of 
K8-null hepatocytes; error bars represent the standard deviation of 
two trials with three different mice. *p-value   0.01. Bar, 10  m. 
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drial-dependent pathway at a step that regulates the initiator
caspase-9 (Wennstrom and Downward, 1999; Krammer,
2000; Roberts et al., 2000). The present results show that
the addition of a beneficial EGF dose activates the Akt-sig-
naling pathway to a level that is essentially identical for both
K8-null and WT hepatocytes, indicating that the EGF-
induced survival against Fas-mediated apoptosis is essentially
independent of the resistance provided by K8/K18. In the
same way, the extent of Akt activation provided by a EGF
dose of 200 ng/dish is high enough to reduce the Fas-medi-
ated apoptosis of K8-null hepatocytes to the level obtained
in WT hepatocytes. These findings are consistent with our
immunolocalization results, suggesting that the resistance
provided by K8/K18 takes place instead at a microtubule-
dependent step that selectively affects Fas density at the
hepatocyte surface.
 
K8/K18 modulate Fas density at the surface membrane
 
Our data show that both K8/K18 and Fas are localized at
the surface membrane of WT hepatocytes. However, al-
though the surface membrane is a major targeting site for
the keratins in WT hepatocytes, a large fraction of Fas is
present in the Golgi compartment before activation (Ben-
nett et al., 1998; Sodeman et al., 2000). Since Fas activa-
tion implies a microtubule-dependent transfer from the
Golgi-sorting compartment to the surface membrane, we
propose that the role of K8/K18 in Fas-mediated apoptosis
is to regulate Fas targeting to the surface membrane. This
interpretation is supported by the observation that a loss of
K8/K18 leads to an increased density of Fas at the mem-
brane (Figs. 4 A and 5 A). Furthermore, as depicted in Fig.
7, recent data in other cell types suggest that the intensity of
the Fas activation is dependent not only on its density at
the surface but also on its degree of clustering, due to a re-
ceptor displacement in the surface membrane plane that is
driven by an actin-dependent process (Parlato et al., 2000).
Assuming that this association holds in hepatocytes, the
data reported in Fig. 6 suggest that in K8-null hepatocytes,
a depolymerization of microtubules can still allow the
transfer of Fas to the cell surface. Although the nature of
the interplay between Fas, K8/K18, microtubules and fi-
brillar actin is unclear, we believe that it involves the par-
ticipation of plectin (Fig. 7), an integrator protein that is
capable of mediating dynamic interactions between IFs,
fibrillar actin, and microtubules (Herrmann and Aebi,
2000). In this regard, it is worth noticing that Fas-depen-
dent activation of caspase-8 leads to a very early specific
cleavage of plectin (Stegh et al., 2000), an event which may
be part of the K8/K18 down-modulation process of Fas tar-
geting.
Previous studies on apoptosis induced in cultured mouse
hepatocytes by various ligands such as TNF-
 
 
 
 and TGF-
 
 
 
have revealed a saturation of the death response at high dose
(Sanchez et al., 1996; Senaldi et al., 1998). The present re-
sults demonstrate a similar saturation at Jo2 concentrations
above 2.5 
 
 
 
g/ml. Jo2 stimulation of Fas-mediated apoptosis
requires the trimerization of the receptor but, as discussed
above, the resulting activation is also dependent on the re-
ceptor density and clustering. It is thus possible that at a
high Jo2 dose the level of Fas trimerization becomes satu-
rated in a manner that is independent of K8/K18 modula-
tion of the Fas density at the surface.
Figure 6. The protection of hepato-
cytes by colchicine against Fas-mediated 
apoptosis is lost when K8/K18 are lack-
ing. (A) Colchicine addition (1  M; 24 h 
before Jo2 stimulation) in primary culture 
protects WT but not K8-null hepatocytes 
against Jo2 (0.5  g/ml) added in the pres-
ence or absence of 0.5  g/ml Act D for
8 h; the addition of  -lumicolchicine 
(1  M) has no effect. (B) Immunostaining 
data showing that the colchicine con-
centration used (1  M for 24 h) disrupts 
the microtubule network in both WT and 
K8-null hepatocytes. (C) Immunofluores-
cence on WT and K8-null hepatocytes 
treated with colchicine (1  M for 24 h), 
showing that Fas is maintained in the 
cytoplasm of WT hepatocytes, whereas it 
is still mostly localized at surface mem-
brane in K8-null hepatocytes. (D) In vivo 
injection of colchicine (400  g/kg) 24 h 
before Jo2 treatment protects WT mice 
against a lethal dose (200  g/kg) of Jo2. 
This protection is reduced in K8-null 
mice. n   13. Bars, 10  m. 
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Biological significance of the K8/K18 IF and 
Fas interplay
 
Fas-mediated apoptosis is an efficient process by which dam-
aged hepatocytes are excluded from the liver (Kanzler and
Galle, 2000). The present results on the response of primary
cultured K8-null versus WT hepatocytes to Fas, TNF-
 
 
 
, or
TRAIL show that K8/K18 IFs provide resistance only
against Fas-mediated apoptosis. The significance of these in
vitro findings is well supported by our complementary in
vivo data demonstrating a large difference in ALT release be-
tween K8-null and WT hepatocytes in response to Jo2 injec-
tion. This is also consistent with the in vivo observation re-
ported by others (Caulin et al., 2000) on the differential
response of K8-null versus WT hepatocytes to the damaging
agent concanavalin-A, a strong inducer of hepatitis in mice
which has the ability to sensitize hepatocytes to Fas L– and
TNF-
 
 
 
–mediated apoptosis (Kusters et al., 1997; Ksontini
et al., 1998; Tagawa et al., 1998, 1997). At any rate, hepato-
cytes are the only epithelial cells where the IFs are made
solely of K8/K18, and we propose that the close interplay
between Fas and K8/K18 is linked to the hepatocyte differ-
entiation program. Moreover, since the K8/K18 pair is
present in all simple epithelial cells, we believe that this new
information on their role in Fas-mediated apoptosis of hepa-
tocytes applies to cells of other simple epithelium origins.
The K8-null mutation provides an extreme alteration of
the usual K8/K18 IF network. We have shown previously
that the reinsertion of the WT K8 gene into K8-null mice
rescues the mechanical integrity of the hepatocyte surface
membrane, implying that the null mutation exerts its action
directly (Loranger et al., 1997). In the same way, the present
data show that the transfer of a complete human K8 cDNA
using a retroviral vector rescues the K8/K18 resistance to Fas-
mediated apoptosis in cultured K8-null hepatocytes (Fig. 1
C). These results demonstrate the biological relevance of our
model system. Moreover, in the light of the present findings
on K8-null hepatocytes, the use of K18-null mice (Magin et
al., 1998) should yield the same type of functional association
between K8/K18 and Fas-mediated apoptosis. Previous anal-
yses of mouse nonepithelial cell lines expressing normal or
mutant human K8 and/or K18 cDNAs or mice carrying such
transgenes have provided significant information on the con-
tribution of the protein domains to resistance to various
forms of stress (Ku et al., 1996, 2001; Oshima et al., 1996).
Our next challenge therefore is to identify which of the par-
ticular K8 and K18 domains, and even which of the putative
phospho–amino acid residues, are providing the protective
resistance to Fas-mediated apoptosis of hepatocytes.
 
Materials and methods
 
Reagents
 
Isoflurane was purchased from Abbott Laboratories Ltd.; and diethyl ether,
from Fisher Scientific. Jo2 (purified hamster anti–mouse Fas monoclonal
antibody, 15400D) and EHS Matrigel Brand (354234) were bought from
BD PharMingen. GPT colorimetric (AL146) Randox kit was obtained from
Randox Laboratories Canada Ltd. Soluble mouse recombinant TRAIL
(Apo2L; SE-722) was bought from BIOMOL Research Laboratories. Colchi-
cine, 
 
 
 
-lumicolchicine, TNF-
 
 
 
, CHX, Act D, and all others reagents were
purchased from Sigma-Aldrich. Human K8 cDNA (p8.1.1) was obtained
from American Type Culture Collection. The antibodies used here were
the following: rabbit anti-Fas (M20) polyclonal antibody (Santa Cruz Bio-
Figure 7. Schematic representation of 
the relevant components of the Fas-sig-
naling pathways in relation to the 
cytoskeletal networks, the Golgi-sorting 
compartment, and the surface mem-
brane. In simple epithelial cells like 
hepatocytes K8/K18, IFs and fibrillar
actin (FA) are largely localized under-
neath the surface membrane, whereas 
microtubules (MT) extend throughout 
the cytoplasm. The Golgi compartment 
(GC), next to the nucleus (N) and the 
endoplasmic reticulum (not shown), is 
involved in the sorting out of the newly 
synthesized receptors, such as Fas and 
EGF Receptor (EGFR), before their 
targeting to appropriate membrane por-
tions, via a microtubule-dependent pro-
cess. A look at the steps of Fas-mediated 
apoptosis indicates that, once the recep-
tor has properly reached the surface 
membrane, the intensity of the Fas 
activation becomes dependent on the 
density of the receptor and on its degree 
of clustering, an actin-dependent pro-
cess. Stimulation by FasL leads to Fas 
trimerization and death-inducing signaling complex formation, which in turn can activate two distinct caspase-signaling pathways classified 
as type I and type II, respectively. Hepatocytes correspond to type II cells, and accordingly, a large part of the death signaling occurs via the 
release of cytochrome C (Cyto C) and subsequently the activation of procaspase-9, and so on. EGF provides protection against Fas-mediated 
apoptosis via an activation of the Akt pathway that leads to the inhibition of caspase-9. c-FLIP, a labile protective protein homologous to 
caspase but exhibiting an inactive catalytic site, regulates death receptor–mediated apoptosis. Significantly, the results reported here suggest 
that K8/K18 largely modulate the Fas density at the hepatocyte surface, in a manner that depends on the participation of microtubules. This 
dynamic interplay may involve a contribution of plectin, a known integrator of the cytoskeletal networks in many cell types.Simple epithelium keratins and Fas apoptosis | Gilbert et al. 771
technology, Inc.); rabbit antiactive caspase-3 polyclonal antibody (BD
PharMingen; rabbit anti–phosphoAkt (Ser473) polyclonal antibody and
mouse anti–phospo-p44/42 mitogen-activated protein kinase (Thr202/
Tyr204) E10 monoclonal antibody (New England Biolabs Inc.); mouse an-
titubulin monoclonal antibody (a gift from Dr. D. Brown, University of Ot-
tawa, Ottawa, Canada); mouse anti-Fas R-phycoerythrin (PE)–labeled
monoclonal antibody (BD PharMingen); rabbit anti–mannosidase II poly-
clonal antibody (provided by Dr. K. Moremen, University of Georgia, Ath-
ens, Georgia); rat anti-K8 monoclonal antibody (TROMA-1; a gift from Dr.
R. Kemler, Max-Planck Institute of Immunobiology, Freiburg, Germany);
HRP goat anti–rabbit Ig and anti–mouse Ig (BIO/CAN); ALEXA 488 goat
anti–mouse immunoglobulin antibody and ALEXA 350 goat anti–rabbit
immunoglobulin antibody (Molecular Probes).
Mice
Details on the establishment, maintenance, and genotyping of the K8-defi-
cient FVB/N mouse line were reported previously (Baribault et al., 1994;
Loranger et al., 1997). The mice were housed in the Specific Pathogen
Free Animal Facility at this research center. In particular, histological mon-
itoring of mouse hepatic tissue for Helicobacter hepaticus revealed no
pathological signs that are usually attributed to the pathogen (Fox et al.,
1996; Ihrig et al., 1999), and PCR-based screening of the mouse feces con-
firmed the absence of the pathogen. The experiments were performed ac-
cording to the rules of the Laval University Animal Care Committee.
Jo2 treatment of mice and hepatocyte damage assessment
The sensitivity of mice to a single i.p. injection of Jo2 depends on the strain
(Sarraf et al., 1997; Hara et al., 2000). Accordingly, we first evaluated the
response of K8-null and WT FVB/N mice to increasing Jo2 concentrations.
A dose of 75  g/kg body weight in 200  l of saline solution resulted in a
90% WT mouse survival (see Results). Just before the injection, a blood
sample was collected from the saphen vein with a nonheparinized capil-
lary tube. At 24 h after injection, a blood sample was obtained by cardiac
puncture while the mouse was under ether anaesthesia. The level of hepa-
tocyte damage was assessed by the amount of ALT released in serum,
based on the level of ALT activity measured with the Randox kit. In some
experiments, mice received an i.p. injection of colchicine at a dose of 400
 g/kg body weight in 200  l of saline solution 24 h before the challenge
with a lethal dose (200  g/kg) of Jo2. The proper colchicine dose was se-
lected after assessment of the ALT activity in response to increasing doses
(0–2000  g/kg); at 400  g/kg, no significant increase in ALT level was
measured in the serum of either K8-null or WT mice before Jo2 injection.
Hepatocyte isolation and culture
Hepatocytes were isolated according to a modified version of the two-step
method with collagenase originally developed for rats (Seglen, 1976; De-
schenes et al., 1980). Mice were anaesthetised with isoflurane, and their
abdominal cavity was opened to cannulate the vena portalis and to section
the vena cava. The liver was perfused at a flow rate of 5 ml/min at 37 C,
first with a Ca
2 -free Hepes, 25 mM buffer, pH 7.5, containing insulin (0.5
 g/ml) and EGTA (0.5 mM), and then with DME/F12 modified medium
containing collagenase (0.2 U Wünsch/ml) and Ca
2  (5 mmol/liter). The
yield of isolated hepatocytes was determined with a hemocytometer, and
their viability evaluated with the standard Trypan blue exclusion assay.
This isolation procedure yielded 6–7   10
7 hepatocytes/liver, with a via-
bility of 90–95%.
Hepatocytes were plated at a density of 1.2   10
5 cells/cm
2 on fibronec-
tin-coated dishes in DME/F12 modified medium supplemented with sele-
nious acid (5  g/l), insulin (5 mg/l), transferrin (5 mg/l), streptomycin (100
 g/ml), and penicillin (100 units/ml). After a 3-h attachment period, the
culture medium was replaced by the same medium supplemented with
dexamethasone (10
 7 M) and EGF (20 ng/ml).
Assessment of apoptosis in culture
At 24 h after seeding, the medium was changed to DME/F12 supplemented
with selenious acid (5  g/liter), transferrin (5 mg/liter), dexamethasone
(10
 7 M), Matrigel (0,5 mg/ml), streptomycin (100  g/ml), and penicillin
(100 units/ml)). The apoptosis inducer (i.e., Jo2, TNF- , TRAIL, or TGF- )
was added in the absence or presence of CHX or Act D, 24 h after the me-
dium change. In some experiments, EGF (20 or 200 ng/dish), colchicine (1
 M), or  -lumicolchicine (1  M) was added 24 h after seeding and then
maintained throughout the experiment.
Apoptotic hepatocytes remained attached to the culture substratum and
were readily detected by Acridine orange staining of the altered chroma-
tin, as described previously (Guilhot et al., 1996). Hepatocytes were exam-
ined with a laser scanning confocal microscope (Bio-Rad MRC-1024)
equipped with a Nikon Diaphot and a krypton–argon laser that emits light
at 488 and 568 nm; the Acridine orange is excited by the 488-nm line.
When one apoptotic hepatocyte exhibited multiple apoptotic bodies, these
were still scored as one. At least 400 cells were counted in six random
fields per dish, and each experiment was repeated in duplicate with at
least three mice. The DNA ladder assay was performed as described (Feng
and Kaplowitz, 2000).
Reinsertion of WT K8 gene into cultured K8-null hepatocytes
A complete human K8 cDNA was transferred into K8-null hepatocytes us-
ing a Moloney murine leukemia retroviral vector derived from MFGb2,
known for providing a high-level gene expression in transduced cells
(Riviere et al., 1995). A retroviral plasmid pGFP3 containing the Herpes
simplex virus TK gene followed by an internal ribosomal entry site se-
quence and a enhanced green fluorescent protein cDNA, was provided by
Dr. M. Caruso (Laval University, Quebec, Canada). To construct the
pK8GFP retroviral plasmid, the NcoI-BamHI TK gene was replaced by the
K8 cDNA, flanked by 5  NcoI and 3  BamHI restriction sites introduced by
PCR. In these vectors, the internal ribosomal entry site allows cap-inde-
pendent translation of the downstream gene, which leads to the translation
of the two proteins from a single mRNA transcribed from the retroviral 5 
long terminal repeat sequence (Martinez-Salas, 1999; Qiao et al., 2000).
For generating the recombinant TK and K8 viruses, GP E-86 packaging
cells (Markowitz et al., 1988) were cotransfected by the calcium phos-
phate procedure with a puro
r plasmid and pGFP3 or pK8GFP, respectively.
After 10 d of selection with 2  g/ml puromycin, resistant clones were iso-
lated, and virus supernatants were harvested and kept frozen at  80 C.
The titration was performed on NIH-3T3 cells (Qiao et al., 2000), by deter-
mining the number of GFP-positive cells after infection at serial dilutions of
virus. The titers obtained for the TK and K8 retroviral vectors were 3   10
6
and 1   10
7 infectious virus/ml, respectively. K8-null hepatocytes were in-
fected 48 h after seeding at a ratio of 10 infectious virus per cell. The me-
dium was changed 16 h after infection, and the apoptosis was induced
with Jo2 (0.5  g/ml) 48 h later, as described above. The gene transfer effi-
ciency, as provided by the proportion of GFP-positve hepatocytes, was
 80%.
Immunofluorescence microscopy and FACS
® analysis
Cultured hepatocytes or liver tissue sections were fixed according to pro-
cedures that varied with the nature of the antigen examined. For multiple
labeling, the cells were rinsed twice in PBS, followed by an incubation in
2% paraformaldehyde in PBS for 10 min at room temperature and a 10
min treatment with 0.1% Triton X-100 at room temperature. After two con-
secutive washes with PBS, the fixed cells were incubated in a blocking so-
lution (10% goat serum in PBS) for 30 min followed by two consecutive
washes with PBS. The labeling was performed with PE-labeled anti-Fas Jo2
(5  g/ml), anti–mannosidase II (1:100), or anti-K8 (TROMA-1) antibody,
followed by 60-min incubations at room temperature with a ALEXA 350–
tagged goat anti–rabbit immunoglobulin antibody or an FITC-labeled goat
anti–rat immunoglobin, respectively. In the case of tubulin, cultured hepa-
tocytes were rinsed in PBS at 37 C followed by a 10-min 37 C incubation
in a fixation buffer that contained 0.1 M Pipes, pH 6.75, 4% PEG-6000, 1
mM EGTA, 1 mM MgSO4, 1% Triton X-100, 2% paraformaldehyde (Caron
et al., 1985). Cells were transferred to  20 C methanol for 5 min. After
two successive 5-min washes in PBS at room temperature, hepatocytes
were incubated overnight at 4 C with the first antibody (i.e., directed
against tubulin), followed by a 60-min incubation at room temperature
with Alexa 488–tagged rabbit anti–mouse immunoglobulin antibody. Im-
ages were captured on an Eclipse TE300 inverted microscope (Nikon) with
a MicroMAX™ interline transfer charge-coupled device camera (Princeton
Instruments) controlled by a Metamorph digital imaging software, or col-
lected with the laser scanning confocal microscope using the laser line
488 nm (Alexa 488; FITC) or 568 nm (PE; Texas red) for fluorochrome ex-
citation and a high numerical aperture (1.4 NA, 60 ) oil immersion objec-
tive. The density of Fas on the surface of freshly isolated hepatocytes was
analyzed by FACS
® as described in detail by Feng and Kaplowitz (2000). In
brief, live cells were washed twice, incubated in proper buffer with 2  g/
ml PE-labeled anti-Fas Jo2 on ice for 20 min, washed three times, and then
analyzed with a FACS
® (Beckman Coulter) using the laser line at 488 nm.
The relative mean fluorescence was calculated with EXPO™ Software,
v2.0 (Applied Cytometry Systems/Beckman Coulter).
Western blotting
Total proteins were extracted with 300  l/35 mm plastic petri dish of pre-
heated at 90 C in 2  SDS-PAGE sample buffer (4  Tris HCl[0,5 M]/
SDS[0,4%], pH 6.8, 20% glycerol, 4% SDS, 2% mercaptoethanol, and 1%772 The Journal of Cell Biology | Volume 154, 2001
Bromophenol blue), as described (Ausubel, 1994). Proteins (10  g) were
separated by PAGE according to Laemmli (1970) and then electrophoreti-
cally transferred onto a PVDF membrane. The blots were incubated with
the primary antibody and then the second antibody conjugated with horse-
radish peroxidase. The staining was revealed with the SuperSignal West
Pico kit (Pierce Chemical Co.).
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